Prognosis is poor.: Angiosarcomas are very rare and aggressive cancers that spread early. 70% of patients die within 5 years of diagnosis. The tumors are made out of newly-formed blood vessels and stimulated to grow by vegf. New biologic therapies, called monoclonal antibodies, are being developed to target these cancerous blood vessels. Not much is know about these tumors due to their rarity.
Answered 12/5/2017
6.3k views
Terminal: It can be, it depends on stage. Recommend having a very clear discussion with oncologist about this especially before treatments are started.
Answered 11/27/2017
5.4k views
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question